Answer
Answer
Tenofovir AF (TAF)
-
25 mg PO once daily
-
Pediatric patients ≥12 years and ≥35 kg: Indicated in combination with other antiretroviral agents
-
Adolescents and children who weigh 25-35 kg: In combination with other antiretroviral agents other than protease inhibitors requiring a CYP3A inhibitor
-
Descovy: Combination formulation including FTC 200 mg/TAF 25 mg;1 tablet PO once daily
Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!
Media Gallery
of
0